Evidence map›Paper›PMID 32575563›Full record

ArticleAntioxidants (Basel, Switzerland)2020

Alterations in the Antioxidant Enzyme Activities in the Neurodevelopmental Rat Model of Schizophrenia Induced by Glutathione Deficiency during Early Postnatal Life.

Magdalena Górny, Anna Bilska-Wilkosz, Małgorzata Iciek, Marta Hereta, Kinga Kamińska, Adrianna Kamińska, Grażyna Chwatko, Zofia Rogóż, Elżbieta Lorenc-Koci

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Green-synthesizedRSC advances · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. PMLife (Basel, Switzerland) · 2023
    Article
  9. Review
  10. Review
  11. Antioxidant Potential-Rich Betel Leaves (Antioxidants (Basel, Switzerland) · 2023
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Magdalena GórnyThe Chair of Medical Biochemistry, Jagiellonian University Medical College, 7 Kopernika Street, 31-034 Kraków, Poland.ORCID 0000-0002-6393-9977
Anna Bilska-WilkoszThe Chair of Medical Biochemistry, Jagiellonian University Medical College, 7 Kopernika Street, 31-034 Kraków, Poland.ORCID 0000-0001-9066-6292
Małgorzata IciekThe Chair of Medical Biochemistry, Jagiellonian University Medical College, 7 Kopernika Street, 31-034 Kraków, Poland.ORCID 0000-0002-0422-0428
Marta HeretaMaj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.
Kinga KamińskaMaj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.ORCID 0000-0002-1359-8860
Adrianna KamińskaDepartment of Environmental Chemistry, University of Łódź, 163 Pomorska Street, 90-236 Łódź, Poland.
Grażyna ChwatkoDepartment of Environmental Chemistry, University of Łódź, 163 Pomorska Street, 90-236 Łódź, Poland.ORCID 0000-0001-9247-5131
Zofia RogóżMaj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.
Elżbieta Lorenc-KociMaj Institute of Pharmacology, Polish Academy of Sciences, 12 Smętna Street, 31-343 Kraków, Poland.ORCID 0000-0002-9970-8548
Maj Institute of Pharmacology · PLJagiellonian University · PLUniversity of Łódź · PL

Funding

National Science Centre of Poland UMO-2016/23/B/NZ7/01280
6 · The paper itself

Abstract

The aim of the present study was to assess the effects of l-buthionine-(S,R)-sulfoximine (BSO), a glutathione (GSH) synthesis inhibitor, and GBR 12909, a dopamine reuptake inhibitor, administered alone or in combination to Sprague-Dawley rats during early postnatal development (p5-p16), on the levels of reactive oxygen species (ROS), lipid peroxidation (LP) and the activities of antioxidant enzymes: superoxide dismutase (SOD), catalase (CAT), glutathione peroxidase (GPx) and glutathione disulfide reductase (GR) in peripheral tissues (liver, kidney) and selected brain structures (prefrontal cortex, PFC; hippocampus, HIP; and striatum, STR) of 16-day-old rats. The studied parameters were analyzed with reference to the content of GSH and sulfur amino acids, methionine (Met) and cysteine (Cys) described in our previous study. This analysis showed that treatment with a BSO + GBR 12909 combination caused significant decreases in the lipid peroxidation levels in the PFC and HIP, in spite of there being no changes in ROS. The reduction of lipid peroxidation indicates a weakening of the oxidative power of the cells, and a shift in balance in favor of reducing processes. Such changes in cellular redox signaling in the PFC and HIP during early postnatal development may result in functional changes in adulthood.

Indexed as

antioxidant enzymes activityGSH deficiencyneurodevelopmental model of schizophreniaROS level

Identifiers

PMID32575563
PMCPMC7346228
OpenAlexW3036481150

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.